Evidence map›Paper›PMID 35495873›Full record

ArticleJournal of toxicology2022

Nephroprotective Effect of

Welela Meka Kedir, Abebe Dukassa Dubiwak, Ebsa Tofik Ahmed

Open access · goldAbstract read
In one paragraph

Article in Journal of toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Veterinary medicine international · 2026
    Article
  2. Article
  3. Evaluation ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Nephroprotective Effect of the Leaf Extract ofJournal of experimental pharmacology · 2024
    Article
  5. Life (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Welela Meka KedirDepartment of Chemistry, College of Natural and Computational Sciences, Mettu University, Mettu, Ethiopia.ORCID https://orcid.org/0000-0001-6134-549X
Abebe Dukassa DubiwakDivision of Medical Biochemistry, Department of Biomedical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia.ORCID https://orcid.org/0000-0002-3260-8382
Ebsa Tofik AhmedDepartment of Biology, College of Natural and Computational Sciences, Mettu University, Mettu, Ethiopia.ORCID https://orcid.org/0000-0001-9399-059X
Ethiopian Civil Service University · ETJimma University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The kidney is the organ most vulnerable to nephrotoxic drugs such as gentamicin. Nephrotoxicity is a rapid deterioration of kidney function due to various factors. Gentamicin causes nephrotoxicity, which was manifested by an increase in serum kidney biomarkers.

Identifiers

PMID35495873
PMCPMC9050328
OpenAlexW4224248235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.